Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 10/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.41 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7637532 | 1.00 | HCAR2 (0.56) | HCAR2ATMTSHRALDH1A1CYP3A4 | |
| SCHEMBL7636696 | 0.97 | HCAR2 (0.59) | HCAR2ATMTSHRALDH1A1CYP3A4 | |
| SCHEMBL7636698 | 0.97 | HCAR2 (0.59) | HCAR2ATMTSHRALDH1A1CYP3A4 | |
| SCHEMBL5973493 | 0.93 | ATM (0.50) | HCAR2ATMTSHRALDH1A1CYP3A4 | |
| SCHEMBL5973993 | 0.93 | ATM (0.50) | HCAR2ATMTSHRALDH1A1CYP3A4 | |
| SCHEMBL5973483 | 0.93 | ATM (0.50) | HCAR2ATMTSHRALDH1A1CYP3A4 | |
| SCHEMBL4565814 | 0.89 | HCAR2 (0.53) | HCAR2ATMTSHRALDH1A1CYP3A4 | |
| SCHEMBL4449421 | 0.89 | HCAR2 (0.53) | HCAR2ATMTSHRALDH1A1CYP3A4 | |
| SCHEMBL4449427 | 0.89 | HCAR2 (0.53) | HCAR2ATMTSHRALDH1A1CYP3A4 | |
| SCHEMBL7638858 | 0.89 | TSHR (0.52) | HCAR2ATMTSHRALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1176136-A1 | PROCESS FOR PRODUCING FUMARIC ESTER | Showa Denko K.K. (JP) | 2002-01-30 | — | — | EP | disclosed |
| US-20020002306-A1 | Method for producing fumaric acid esters | SHOWA DENKO K.K. (JP) | 2002-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020002306-A1 | Method for producing fumaric acid esters | FH, ME1, ME3 | HCAR2 750/4885ATM 3076/4885TSHR 4711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.